• Feedback
  • RSS Feed
  • Sitemap
Ommcom News
  • Home
  • Odisha
  • Nation
  • World
  • Sports
  • Business
  • Entertainment
  • Videos
  • Science & Tech
  • Photo Gallery
  • ଓଡ଼ିଆରେ ପଢନ୍ତୁ
No Result
View All Result
  • Home
  • Odisha
  • Nation
  • World
  • Sports
  • Business
  • Entertainment
  • Videos
  • Science & Tech
  • Photo Gallery
  • ଓଡ଼ିଆରେ ପଢନ୍ତୁ
No Result
View All Result
Odisha News, Odisha Breaking News, Odisha Latest News || Ommcom News
Home Science & Tech

Postpartum Depression Pill Safe & Effective: Study

OMMCOM NEWS by OMMCOM NEWS
July 28, 2023
in Science & Tech
Postpartum

New York:  A pill used for postpartum depression (PPD) is safe for use and has shown to be effective in managing symptoms, results of a new study has shown.

PPD is a common perinatal complication experienced by one in eight women and has adverse maternal and infant outcomes.

Zuranolone, developed by Sage Therapeutics and Biogen, is an oral, once-daily neuroactive steroid pill used in a 14-day treatment course for patients with severe PPD.

“In the trial, zuranolone demonstrated significant improvements in depressive symptoms and was generally well tolerated, supporting the potential of zuranolone as a novel, rapid-acting oral treatment for PPD,” said researchers of the trial published in The American Journal of Psychiatry.

About 57 per cent of the women taking zuranolone experienced a 50 per cent or more improvement in their depressive symptoms at day 15, versus 38 per cent of women taking placebo.

At day 45, 61.9 per cent of the trial participants who received zuranolone compared to 54.1 per cent of women receiving placebo, experienced a 50 per cent or more improvement in their depressive symptoms.

“Postpartum depression is under recognised, undertreated and disruptive for those who live with the condition. We collaborate with researchers around the world in an effort to develop more rapid and effective therapies for the many women who need support,” said lead author Kristina M. Deligiannidis, professor at the Institute of Behavioral Science at the Feinstein Institutes, and the trial’s principal investigator.

“We have been working on neuroactive steroid research in PPD for nearly 15 years. The study follows previous successful clinical trials, and publishing its results is a pinnacle moment in treating postpartum depression,” she added.

The results showed rapid and clinically meaningful improvements in depressive symptoms at measured time points and have prompted a “priority review” by the US Food and Drug Administration (FDA).

A Priority Review designation will direct overall attention and resources to the evaluation of applications for drugs that, if approved, would be significant improvements in the safety or effectiveness of the treatment, diagnosis, or prevention of serious conditions when compared to standard applications.

The FDA is expected to make a decision and take action on approval by August 5.

(IANS)

Tags: PostpartumUS Food
ShareTweetSendSharePinShareSend
Previous Post

Air Force Base, Settlements Evacuated In Greece As Wildfires Rage

Next Post

Odisha Vigilance Arrests Nayagarh Addl Tahashildar For Accepting Bribe

Related Posts

Science & Tech

Australian Scientists’ Genetic Barcoding Decodes Early Human Development

June 25, 2025
Science & Tech

Millions Of Children At Risk As Global Childhood Vaccination Rates Plummet Since 2010: Lancet

June 25, 2025
Science & Tech

Imported Seafood Increasing Resistance To Colistin, A Potent Antibiotic: Study

June 22, 2025
Science & Tech

Sickle Cell Elimination Mission Ensured Regular Treatment At Primary Care Centres: ICMR-CRMCH

June 21, 2025
South Korea
Science & Tech

South Korea’s Space Agency Aims To Develop Reusable Launch Vehicle By 2035

June 20, 2025
Science & Tech

QS Rankings 2026 Features Record 54 Indian Institutes, IIT Delhi Tops

June 19, 2025
Next Post

Odisha Vigilance Arrests Nayagarh Addl Tahashildar For Accepting Bribe

Shilpa Shetty

Shilpa Shetty Calls Nagaland’s ‘Mahila Band’ 'Perfect Representation Of India'

Manipur Viral Videos: SC Could Not Take Up Pleas For Hearing

khimji
OMC
  • Feedback
  • RSS Feed
  • Sitemap

© 2025 - Ommcom News. All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

No Result
View All Result
  • Home
  • Odisha
  • Nation
  • World
  • Sports
  • Business
  • Entertainment
  • Videos
  • Science & Tech
  • Photo Gallery
  • ଓଡ଼ିଆରେ ପଢନ୍ତୁ

© 2025 - Ommcom News. All Rights Reserved.